Brief: Cytodyn Reports Early, But Strong Positive Clinical Responses For 2 Patients
23/12/2019 11:11
Dec 23 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN REPORTS EARLY, BUT STRONG POSITIVE CLINICAL
RESPONSES
FOR TWO PATIENTS, ONE IN METASTATIC BREAST CANCER AND ONE IN
METASTATIC TRIPLE-NEGATIVE BREAST CANCER TRIALS
Source text for Eikon: ID:nGNX72ZYdW
Further company coverage: CYDY.PK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer